Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philipp A. Lang is active.

Publication


Featured researches published by Philipp A. Lang.


Journal of Clinical Investigation | 2012

The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells

Anne Brüstle; Dirk Brenner; Christiane B. Knobbe; Philipp A. Lang; Carl Virtanen; Brian M. Hershenfield; Colin Reardon; Sonja M. Lacher; Jürgen Ruland; Pamela S. Ohashi; Tak W. Mak

Effector functions of inflammatory IL-17-producing Th (Th17) cells have been linked to autoimmune diseases such as experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). However, what determines Th17 cell encephalitogenicity is still unresolved. Here, we show that after EAE induction, mice deficient for the NF-κB regulator MALT1 (Malt1-/- mice) exhibit strong lymphocytic infiltration in the CNS, but do not develop any clinical signs of EAE. Loss of Malt1 interfered with expression of the Th17 effector cytokines IL-17 and GM-CSF both in vitro and in vivo. In line with their impaired GM-CSF secretion, Malt1-/- Th cells failed to recruit myeloid cells to the CNS to sustain neuroinflammation, whereas autoreactive WT Th cells successfully induced EAE in Malt1-/- hosts. In contrast, Malt1 deficiency did not affect Th1 cells. Despite their significantly decreased secretion of Th17 effector cytokines, Malt1-/- Th17 cells showed normal expression of lineage-specific transcription factors. Malt1-/- Th cells failed to cleave RelB, a suppressor of canonical NF-κB, and exhibited altered cellular localization of this protein. Our results indicate that MALT1 is a central, cell-intrinsic factor that determines the encephalitogenic potential of inflammatory Th17 cells in vivo.


Journal of Experimental Medicine | 2010

Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency

Jolan E. Walter; Francesca Rucci; Laura Patrizi; Mike Recher; Stephan Regenass; Tiziana Paganini; Marton Keszei; Itai M. Pessach; Philipp A. Lang; Pietro Luigi Poliani; Silvia Giliani; Waleed Al-Herz; Morton J. Cowan; Jennifer M. Puck; Jack Bleesing; Tim Niehues; Catharina Schuetz; Harry L. Malech; Suk See DeRavin; Fabio Facchetti; Andrew R. Gennery; Emma Andersson; Naynesh Kamani; JoAnn Sekiguchi; Hamid M. Alenezi; Javier Chinen; Ghassan Dbaibo; Gehad ElGhazali; Adriano Fontana; Srdjan Pasic

The contribution of B cells to the pathology of Omenn syndrome and leaky severe combined immunodeficiency (SCID) has not been previously investigated. We have studied a mut/mut mouse model of leaky SCID with a homozygous Rag1 S723C mutation that impairs, but does not abrogate, V(D)J recombination activity. In spite of a severe block at the pro–B cell stage and profound B cell lymphopenia, significant serum levels of immunoglobulin (Ig) G, IgM, IgA, and IgE and a high proportion of Ig-secreting cells were detected in mut/mut mice. Antibody responses to trinitrophenyl (TNP)-Ficoll and production of high-affinity antibodies to TNP–keyhole limpet hemocyanin were severely impaired, even after adoptive transfer of wild-type CD4+ T cells. Mut/mut mice produced high amounts of low-affinity self-reactive antibodies and showed significant lymphocytic infiltrates in peripheral tissues. Autoantibody production was associated with impaired receptor editing and increased serum B cell–activating factor (BAFF) concentrations. Autoantibodies and elevated BAFF levels were also identified in patients with Omenn syndrome and leaky SCID as a result of hypomorphic RAG mutations. These data indicate that the stochastic generation of an autoreactive B cell repertoire, which is associated with defects in central and peripheral checkpoints of B cell tolerance, is an important, previously unrecognized, aspect of immunodeficiencies associated with hypomorphic RAG mutations.


Journal of Experimental Medicine | 2012

The E3 ubiquitin ligase Mule acts through the ATM–p53 axis to maintain B lymphocyte homeostasis

Zhenyue Hao; Gordon S. Duncan; Yu-Wen Su; Wanda Y. Li; Jennifer Silvester; Claire Hong; Han You; Dirk Brenner; Chiara Gorrini; Jillian Haight; Andrew Wakeham; Annick You-Ten; Susan McCracken; Andrew Elia; Qinxi Li; Jacqui Detmar; Andrea Jurisicova; Elias Hobeika; Michael Reth; Yi Sheng; Philipp A. Lang; Pamela S. Ohashi; Qing Zhong; Xiaodong Wang; Tak W. Mak

Genetic manipulation reveals that Mule is vital for B cell development, proliferation, and homeostasis as a result of its ability to regulate p53 and ATM.


Proceedings of the National Academy of Sciences of the United States of America | 2011

14-3-3σ regulates B-cell homeostasis through stabilization of FOXO1

Yu-Wen Su; Zhenyue Hao; Atsushi Hirao; Kazuo Yamamoto; Wen-Jye Lin; Ashley Young; Gordon S. Duncan; Hiroki Yoshida; Andrew Wakeham; Philipp A. Lang; Kiichi Murakami; Heiko Hermeking; Bert Vogelstein; Pamela S. Ohashi; Tak W. Mak

14-3-3σ regulates cytokinesis and cell cycle arrest induced by DNA damage but its role in the immune system is unknown. Using gene-targeted 14-3-3σ–deficient (i.e., KO) mice, we studied the role of 14-3-3σ in B-cell functions. Total numbers of B cells were reduced by spontaneous apoptosis of peripheral B cells. Upon B-cell antigen receptor engagement in vitro, KO B cells did not proliferate properly or up-regulate CD86. In response to T cell-independent antigens, KO B cells showed poor secretion of antigen-specific IgM. This deficit led to increased lethality of KO mice after vesicular stomatitis virus infection. KO B cells showed elevated total FOXO transcriptional activity but also increased FOXO1 degradation. Coimmunoprecipitation revealed that endogenous 14-3-3σ protein formed a complex with FOXO1 protein. Our results suggest that 14-3-3σ maintains FOXO1 at a consistent level critical for normal B-cell antigen receptor signaling and B-cell survival.


Clinical Immunology | 2010

Defects of B Cell Tolerance and Expansion of Immunoglobulin Secreting Cells in Rag-dependent Immunodeficiency

Jolan E. Walter; Francesca Rucci; Cynthia Detre; Laura Patrizi; Mike Recher; Marton Keszei; Itai M. Pessach; Philipp A. Lang; Stephan Regenass; JoAnn Sekiguchi; Frederick W. Alt; Luigi D. Notarangelo


Archive | 2013

virus-induced disease derived interferon controls viral replication and - Hematopoietic cell

Karl S. Lang; Marc Pellegrini; Lukas Flatz; Andreas Bergthaler; Kenya Honda; Burkhard Ludewig; S Pamela; Philipp A. Lang; Luisa Cervantes-Barragan; Admar Verschoor; Alexander A. Navarini; Mike Recher


Archive | 2013

Compositions containing soluble toso protein and uses thereof

Michael W. Tusche; Tak W. Mak; Pamela S. Ohashi; Philipp A. Lang; Karl S. Lang; Dirk Brenner; Gloria H. Y. Lin


Archive | 2013

Procédés et compositions pour moduler l'activité toso

Michael W. Tusche; Tak W. Mak; Pamela S. Ohashi; Philipp A. Lang; Karl S. Lang; Dirk Brenner; Gloria H. Y. Lin


/data/revues/00916749/v131i3/S0091674912015400/ | 2013

Iconography : Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency

Philipp A. Lang; Namir Shaabani; Stephanie Borkens; Nadine Honke; Stefanie Scheu; Sarah Booth; Dirk Brenner; Andreas Meryk; Carmen Barthuber; Mike Recher; Tak W. Mak; Pamela S. Ohashi; Dieter Häussinger; Gillian M. Griffiths; Aj Thrasher; Gerben Bouma; Karl S. Lang


Archive | 2012

compartment in mice (WASp) causes severe abnormalities of the peripheral B-cell intrinsic deficiency of the Wiskott-Aldrich syndrome protein - B cell

Scott B. Snapper; Karl S. Lang; Richard Malley; Lisa Westerberg; Aj Thrasher; Michel J. Massaad; George C. Tsokos; John H. Hartwig; John P. Manis; S Raif; Ottavia M. Delmonte; Francesco Frugoni; Angela B. Ferraz Fomin; David Buchbinder; Masayuki Mizui; Eva Csizmadia; Fabio Candotti; Kari C. Nadeau; Gerben Bouma; Kristin Moffitt; Nadine Honke; Philipp A. Lang; Laura Patrizi; Hervé Falet; Mike Recher; Siobhan O. Burns; Miguel Angel de la Fuente; Stefano Volpi; Carin I. M. Dahlberg; E Jolan

Collaboration


Dive into the Philipp A. Lang's collaboration.

Top Co-Authors

Avatar

Pamela S. Ohashi

Princess Margaret Cancer Centre

View shared research outputs
Top Co-Authors

Avatar

Karl S. Lang

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tak W. Mak

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Laura Patrizi

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Andrew Wakeham

University Health Network

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zhenyue Hao

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Tak W. Mak

University Health Network

View shared research outputs
Researchain Logo
Decentralizing Knowledge